FR3002228B1 - MONOCLONAL ANTIBODIES AND USES - Google Patents

MONOCLONAL ANTIBODIES AND USES

Info

Publication number
FR3002228B1
FR3002228B1 FR1351368A FR1351368A FR3002228B1 FR 3002228 B1 FR3002228 B1 FR 3002228B1 FR 1351368 A FR1351368 A FR 1351368A FR 1351368 A FR1351368 A FR 1351368A FR 3002228 B1 FR3002228 B1 FR 3002228B1
Authority
FR
France
Prior art keywords
monoclonal antibodies
monoclonal
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1351368A
Other languages
French (fr)
Other versions
FR3002228A1 (en
Inventor
Helene Gary
Dalloul Ali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris Sud Paris 11
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris Sud Paris 11
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Universite Paris Sud Paris 11 filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR1351368A priority Critical patent/FR3002228B1/en
Priority to PCT/IB2014/059059 priority patent/WO2014125455A1/en
Publication of FR3002228A1 publication Critical patent/FR3002228A1/en
Application granted granted Critical
Publication of FR3002228B1 publication Critical patent/FR3002228B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR1351368A 2013-02-18 2013-02-18 MONOCLONAL ANTIBODIES AND USES Expired - Fee Related FR3002228B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1351368A FR3002228B1 (en) 2013-02-18 2013-02-18 MONOCLONAL ANTIBODIES AND USES
PCT/IB2014/059059 WO2014125455A1 (en) 2013-02-18 2014-02-18 Anti-receptor cd5 monoclonal antibody having multiple uses in medicine and in cancer research

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1351368A FR3002228B1 (en) 2013-02-18 2013-02-18 MONOCLONAL ANTIBODIES AND USES

Publications (2)

Publication Number Publication Date
FR3002228A1 FR3002228A1 (en) 2014-08-22
FR3002228B1 true FR3002228B1 (en) 2016-02-19

Family

ID=48570262

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1351368A Expired - Fee Related FR3002228B1 (en) 2013-02-18 2013-02-18 MONOCLONAL ANTIBODIES AND USES

Country Status (2)

Country Link
FR (1) FR3002228B1 (en)
WO (1) WO2014125455A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109752548B (en) * 2019-02-01 2022-05-06 广州金域医学检验中心有限公司 Combined reagent and system for evaluating prognosis of chronic lymphocytic leukemia
US20240092925A1 (en) * 2021-01-12 2024-03-21 Nanjing IASO Biotechnology Co., Ltd. Cd5-targeting fully humanized antibody
CN113105547B (en) * 2021-05-18 2022-04-08 福州迈新生物技术开发有限公司 anti-CD 5 protein monoclonal antibody and cell strain, preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8136295U1 (en) 1981-12-12 1982-04-22 ACO Severin Ahlmann GmbH & Co KG, 2370 Rendsburg DRAINAGE GUTTER WITH COVER
US4466554A (en) 1982-04-01 1984-08-21 Bud Antle, Inc. Singulating seeder for high density plug trays
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US9066986B2 (en) * 2010-10-01 2015-06-30 National Research Council Of Canada Anti-CEACAM6 antibodies and uses thereof

Also Published As

Publication number Publication date
WO2014125455A1 (en) 2014-08-21
FR3002228A1 (en) 2014-08-22

Similar Documents

Publication Publication Date Title
FR23C1019I2 (en) ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
FR24C1019I1 (en) ANTI-FCRN ANTIBODIES
MA49034A (en) ANTI-LAG3 ANTIBODY
FR23C1036I2 (en) ANTIBODIES THAT BIND TO IL-23
CL2016001646A1 (en) Antibodies and anti-sight fragments
MA49537A (en) ANTI-LAG3 ANTIBODIES AND THEIR USES
MA47268A (en) ANTIBODY ANTI-GPC3
DK3683235T3 (en) Anti-IL-33 antibodies and uses thereof
MA45004A (en) ANTI-WT1-HLA SPECIFIC ANTIBODIES
CL2016001102A1 (en) Novel anti-claudin antibodies and methods of use.
DK3336106T3 (en) ANTI-FCRH5 ANTIBODIES
CO7071096A2 (en) Anti-lgr5 and immunoconjugate antibodies
CL2015001924A1 (en) Anti-pdgfr-beta antibodies and related uses.
BR112015002193A2 (en) anti-etbr and immunoconjugate antibodies
DK3027209T3 (en) Anti-Activin A Antibodies and Uses thereof
MA45125A (en) ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND THEIR USES
DK3049441T3 (en) Anti-PDL1 antibody formulations
DK3026062T3 (en) ANTI-PD-1 ANTIBODY AND ITS USE
DK3708583T3 (en) NON-FUCOSYLED ANTI-FGFR2IIIB ANTIBODIES
DK3381943T3 (en) ANTI-KIT ANTIBODIES AND USES THEREOF
CL2015003496A1 (en) Therapeutic anti-wall and conjugate antibodies.
MA45233A (en) ANTI-GITR ANTIBODIES AND THEIR USES
DK3480215T3 (en) Anti-HER2 antibody and conjugate thereof
CL2015002750A1 (en) Pac1 human antibodies
MA46704A (en) ANTI-PYROGLUTAMATE- AMYLOID-BETA ANTIBODIES AND THEIR USES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20191005